1. TremolaterraF, VilloriaA, SerraJ, et al.Intestinal tone and gas motion. Neurogastroenterol Motil 2006;18:905. CrossRef

2. SteadmanC, PhillipsSF, CamilleriM, et al.Variation of muscle tone in the human colon. Gastroenterology 1991;101:373.

3. McFarlaneGT, CummingsJH. The colonic flora, fermentation and large bowel digestive function. In: PhillipsSF, PembertonJH, ShorterRG(eds). The Large Intestine. New York: Raven Press; 1991: 51.

4. SchufflerMD, PopeCEII. Studies of idiopathic intestinal pseudoobstruction. II. Hereditary hollow visceral myopathy: family studies. Gastroenterology1977;73:339.

5. LewisTD, DanielEE, SarnaSK, et al.Idiopathic intestinal pseudoobstruction. Report of a case, with intraluminal studies of mechanical and electrical activity, and response to drugs. Gastroenterology 1978;74:109.

6. FaulkDL, AnurasS, GardnerGD, et al.A familial visceral myopathy. Ann Intern Med 1978;89:600. CrossRef

7. ShawA, ShafferH, TejaK, et al.A perspective for pediatric surgeons: chronic idiopathic intestinal pseudoobstruction. J Pediatr Surg 1979;14:719. CrossRef

8. WeissW. Zur Atiologie des Megaduodenums. Dtsch Z Chir 1938;251:317. CrossRef

9. LawDH, Ten EyckEA. Familial megaduodenum and megacystis. Am J Med 1961;33:911. CrossRef

10. NewtonWT. Radical enterectomy for hereditary megaduodenum. Arch Surg 1968;96:549. CrossRef

11. SchufflerMD, RohrmannCA, ChafferRG, et al.Chronic intestinal pseudoobstruction. A report of 27 cases and review of the literature. Medicine1981;60:173. CrossRef

12. DucastelleT, TranvouezJL, LereboursE, et al.Myopathie viscérale héréditaire: une entité acute au sein des pseudo‐obstructions intestinales idiopathiques. Gastroenterol Clin Biol1986;10:355.

13. RodriguesCA, ShepherdNA, Lennard‐JonesJE, et al.Familial visceral myopathy: a family with at least six involved members. Gut1989;30:1285. CrossRef

14. AnurasS, BakerCRFJr, CarterJ, et al.Subtotal duodenectomy for massive dilatation of duodenum in patients with type I familial visceral myopathy. Gastroenterology1990;98:A323.

15. EavesER, SchmidtGT. Chronic idiopathic megaduodenum in a family. Aust N Z J Med1985;15:1. CrossRef

16. JonesSC, DixonMF, LintottDJ, et al.Familial visceral myopathy: a family with involvement of four generations. Dig Dis Sci1992;37:464. CrossRef

17. BannisterR, HoyesAD. Generalised smooth‐muscle disease with defective muscarinic‐receptor function. Br Med J1981;282:1015. CrossRef

18. AnurasS, MitrosFA, NowakTV, et al.A familial visceral myopathy with external ophthalmoplegia and autosomal recessive transmission. Gastroenterology1983;84:346.

19. IonasescuVV, ThompsonHS, AschenbrenerC, et al.Late‐onset oculogastrointestinal muscular dystrophy. Am J Med Genet1984;18:781. CrossRef

20. AnurasS. A new family of small intestinal diverticulosis and external ophthalmoplegia. Gastroenterology1986;90:1328.

21. FaberJ, FichA, SteinbergA, et al.Familial intestinal pseudoobstruction dominated by a progressive neurologic disease at a young age. Gastroenterology1987;92:786.

22. IgarashiM, MacRaeD, O‐UchiT, et al.Cochleo‐saccular degeneration in one of three sisters with hereditary deafness, absent gastric motility, small bowel diverticulosis and progressive sensory neuropathy. J Otorhinolaryngol Relat Spec1981;43:4. CrossRef

23. MulderNH, QueGS, BartelinkA, et al.Triad of duodenal megabulbus, diverticula and gastric atony in four siblings. Neth J Med1983;26:120.

24. BardosiA, CreutfeldtW, DiMauroS, et al.Myo‐, neuro‐, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome‐c‐oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (Berl)1987;74:248. CrossRef

25. CerveraR, BruixJ, BayesA, et al.Chronic intestinal pseudoobstruction and ophthalmoplegia in a patient with mitochondrial myopathy. Gut1988;29:544. CrossRef

26. CaveDR, ComptonCC. Case records of the Massachusetts General Hospital. Case 12‐1990. N Engl J Med1990;322:829. CrossRef

27. JacobE, ArdichviliD, PerissinoA, et al.A case of familial visceral myopathy with atrophy and fibrosis of the longitudinal muscle layer of the entire small bowel. Gastroenterology1979;77:745.

28. AnurasS, MitrosFA, MilanoM, et al.A familial visceral myopathy with dilation of the entire gastrointestinal tract. Gastroenterology1986;90:385.

29. AlsteadEM, MurphyMN, FlanaganAM, et al.Familial autonomic visceral myopathy with degeneration of muscularis mucosae. J Clin Pathol1988;41:424. CrossRef

30. StrosbergJM, PeckB, HarrisEDJr. Scleroderma with intestinal involvement: fatal in two of a kindred. J Rheumatol1977;4:46.

31. AnurasS, MitrosFA, SoperRT, et al.Chronic intestinal pseudoobstruction in young children. Gastroenterology1986;91:62.

32. KapilaL, HaberkornS, NixonHH. Chronic adynamic bowel simulating Hirschsprung disease. J Pediatr Surg1975;10:885. CrossRef

33. BagwellCE, FillerRM, CutzE, et al.Neonatal intestinal pseudoobstruction. J Pediatr Surg1984;19:732. CrossRef

34. StaffordSJ, UlshenMH, MandellJ. Familial visceral myopathy. J Urol1983;131:978.

35. SchufflerMD, PagonRA, SchwartzR, et al.Visceral myopathy of the gastrointestinal and genitourinary tracts in infants. Gastroenterology1988;94:892.

36. GlassmanM, SpivakW, MininbergD, et al.Chronic idiopathic intestinal pseudoobstruction: a commonly misdiagnosed disease in infants and children. Pediatrics1989;83:603.

37. KaschulaRDC, CywesS, KatzA, et al.Degenerative leiomyopathy with massive megacolon. Myopathic form of chronic idiopathic intestinal pseudoobstruction occurring in indigenous Africans. Perspect Pediatr Pathol1987;11:193.

38. JayachandraJ, FrankJL, JonasMM. Isolated intestinal myopathy resembling progressive systemic sclerosis in a child. Gastroenterology1988;95:1114.

39. NonakaM, GouletO, ArahanP, et al.Primary intestinal myopathy, a cause of chronic idiopathic intestinal pseudoobstruction syndrome (CIPS): clinico‐pathological studies of seven cases in children. Pediatr Pathol1989;9:409. CrossRef

40. BerdonWE, BakerDH, BlancWA, et al.Megacystis‐microcolon‐intestinal hypoperistalsis syndrome: a new cause of intestinal obstruction in the newborn. Report of radiologic findings in five newborn girls. Am J Roentgenol1976;126:957. CrossRef

41. WiswellTE, RawlingsJS, WilsonJL, et al.Megacystis‐microcolon‐intestinal hypoperistalsis syndrome. Pediatrics1979;63:805.

42. JonaJA, WerlinSL. The megacystis microcolon intestinal hypoperistalsis syndrome: report of a case. J Pediatr Surg1981;16:749. CrossRef

43. AmouryRA, FellowsRA, GoodwinCD, et al.Megacystis‐microcolon‐intestinal hypoperistalsis syndrome: a cause of intestinal obstruction in the newborn period. J Pediatr Surg1977;12:1063. CrossRef

44. VezinaWC, MorinFR, WinsbergF. Megacystis‐microcolon‐intestinal hypoperistalsis syndrome: antenatal ultrasound appearance. Am J Roentgenol1979;133:749. CrossRef

45. YoungLW, YunisEJ, GirdamyBR, et al.Megacystis‐microcolon‐intestinal hypoperistalsis syndrome: additional clinical, radiologic, surgical and histopathologic aspects. Am J Roentgenol1981;137:749. CrossRef

46. PuriP, LakeBD, GormanF, et al.Megacystis‐microcolon‐intestinal hypoperistalsis syndrome: a visceral myopathy. J Pediatr Surg1983;18:64. CrossRef

47. OliveiraG, BoechatMI, FerreiraMA. Megacystis‐microcolon‐intestinal hypoperistalsis syndrome in the newborn girl whose brother had prune belly syndrome: common pathogenesis?Pediatr Radiol1983;13:294. CrossRef

48. GillisDA, GrantmyreEB. Megacystis‐microcolon‐intestinal hypoperistalsis syndrome: survival of a male infant. J Pediatr Surg1985;20:279. CrossRef

49. TomomasaT, ItohZ, KoizumiT, et al.Manometric study on the intestinal motility in a case of megacystis‐microcolon‐intestinal hypoperistalsis syndrome. J Pediatr Gastroenterol Nutr1985;4:307. CrossRef

50. WinterRM, KnowlesSAS. Megacystis‐microcolon‐intestinal hypoperistalsis syndrome: confirmation of autosomal recessive inheritance. J Med Genet1986;23:360. CrossRef

51. PenmanDG, LilfordRJ. The megacystis‐microcolon‐intestinal hypoperistalsis syndrome: a fatal autosomal recessive condition. J Med Genet1989;26:66. CrossRef

52. FarrellSA. Intrauterine death in megacystis‐microcolon‐intestinal hypoperistalsis syndrome. J Med Genet1988;25:350. CrossRef

53. TaguchiT, IkedaK, ShonoT, et al.Autonomic innervation of the intestine from a baby with megacystis microcolon intestinal hypoperistalsis syndrome. I. Immunohistochemical study. J Pediatr Surg1989;24:1264. CrossRef

54. KubotaM, IkedaK, ItoY. Autonomic innervation of the intestine from a baby with megacystis microcolon intestinal hypoperistalsis syndrome. II. Electrophysiological study. J Pediatr Surg1989;24:1267. CrossRef

55. YoungID, McKeeverPA, BrownLA, et al.Prenatal diagnosis of the megacystis‐microcolon‐intestinal hypoperistalsis syndrome. J Med Genet1989;26:403. CrossRef

56. DogruyolH, GunayU, EsmerA, et al.Megacystis‐microcolon‐intestinal hypoperistalsis syndrome in a newborn after clomiphene ingestion during pregnancy. Z Kinderchir1987;42:321.

57. VinogradI, MogleP, LernauOZ, et al.Megacystis‐microcolon‐intestinal hypoperistalsis syndrome. Arch Dis Child1984;59:169. CrossRef

58. RoyAD, BharuchaH, NevinNC, et al.Idiopathic intestinal pseudoobstruction: a familial visceral neuropathy. Clin Genet1980;18:291. CrossRef

59. MayerEA, SchufflerMD, RotterJI, et al.Familial visceral neuropathy with autosomal dominant transmission. Gastroenterology1986;91:1528.

60. AnurasS, MukherjeeSK, DunnD, et al.A new family with autosomal dominant transmitted visceral neuropathy. Gastroenterology1988;94:A10.

61. KernIB, HarrisMJ. Congenital short bowel. Aust N Z J Surg1973;42:283. CrossRef

62. RoyerP, RicourC, Nihoul‐FeketeC, et al.Le syndrome familial de grèle court avec malrotation intestinale et sténose hypertrophique du pylore chez le nourrison. Arch Franc Pediatr1974;31:223.

63. TannerMS, SmithB, LloydJK. Functional intestinal obstruction due to deficiency of argyrophil neurones in the myenteric plexus. Familial syndrome presenting with short small bowel. Gastroenterology1976;84:346.

64. LaugierMMJ, MercierC, RobertM, et al.Syndrome de grèle court avec malrotation intestinale et sténose hypertrophique du pylore. Bordeaux Med1975;8:419.

65. NezelofC, JaubertF, LyonG. Syndrome familial associant grèle court, malrotation intestinale, hypertrophie du pylore et malformation cérébrale: étude anatomo‐clinique de trois observations. Ann Anat Pathol1976;21:401.

66. SansaricqC, ChenWJ, MankaM, et al.Familial congenital short small bowel with associated defects. Clin Pediatr1983;23:453. CrossRef

67. HarrisDJ, AshcraftKW, BeattyEC, et al.Natal teeth, patent ductus arteriosus and intestinal pseudoobstruction: a lethal syndrome in the newborn. Clin Genet1976;9:479. CrossRef

68. SchufflerMD, BirdTD, SumiM, et al.A familial neuronal disease presenting as intestinal pseudoobstruction. Gastroenterology1978;75:889.

69. CockelR, HillEE, RushtonDI, et al.Familial steatorrhea with calcification of the basal ganglia and mental retardation. Q J Med1973;42:771.

70. ByrneWJ, CipelL, EulerAR, et al.Chronic idiopathic intestinal pseudoobstruction syndrome in children—clinical characteristics and prognosis. J Pediatr1977;90:585. CrossRef

71. TalleyNJ, O'KeefeEA, ZinsmeisterAR, et al.Prevalence of gastrointestinal symptoms in the elderly: a population‐based study. Gastroenterology1992;102:895.

72. TalleyNJ, WeaverAL, ZinsmeisterAR, et al.Functional constipation and outlet delay: a population‐based study. Gastroenterology1993;105:781. CrossRef

73. SuaresNC, FordAC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta‐analysis. Am J Gastroenterol2011;106:1582. CrossRef

74. WaldA, ScarpignatoC, Mueller‐LissnerS, et al.A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation. Aliment Pharmacol Ther2008;28:917.

75. AltobelliG, BadialiD, CorazziariE. Does irritable bowel syndrome diagnosis change with the Rome II diagnostic criteria?Gastroenterol Int2000;13:91.

76. WoodJD, GrundyD. Little brain–big brain V. Neurogastroenterol Motil1998;10:377. CrossRef

77. WoodJD. Enteric neurophysiology. Am J Physiol1984;247:G585.

78. Faussone‐PellegriniMS, CortesiniC, RomagnoliP. Ultrastructure of the tunica muscularis of the cardial portion of the human esophagus and stomach, with special reference to the so‐called Cajal's interstitial cells [in Italian]. Arch Ital Anat Embriol1977;82:157.

79. Faussone‐PellegriniMS, CortesiniC. Some ultrastructural features of the muscular coat of human small intestine. Acta Anat1983;15:47.

80. ThunebergL. Interstitial cells of Cajal: intestinal pacemaker cells?Adv Anat Embryol Cell Biol1982;71:1. CrossRef

81. FurnessJB, KunzeWA, ClercN. Nutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses. Am J Physiol1999;277:G922.

82. XiaY, HuHZ, LiuS, et al.IL‐1beta and IL‐6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system. J Clin Invest1998;103:1309. CrossRef

83. LomaxAE, LindenDR, MaweGM, et al.Effects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits. Auton Neurosci2006;126–127:250. CrossRef

84. Le DouarinNM. The Neural Crest. Cambridge, UK: Cambridge University Press; 1982.

85. DurbecPL, Larsson‐BlombergLB, SchuchardtA, et al.Common origin and developmental dependence on c‐ret of subsets of enteric and sympathetic neuroblasts. Development1996;122:349.

86. PomeranzHD, RothmanTP, GershonMD. Colonization of the post‐umbilical bowel by cells derived from the sacral neural crest: direct tracing of cell migration using an intercalating probe and a replication‐deficient retrovirus. Development1991;111:647.

87. FuCG, MutoT, MasakiT, et al.Zonal adult Hirschsprung disease. Gut1996;39:765. CrossRef

88. TennysonVM, GershonMD, ShermanDL, et al.Structural abnormalities associated with the congenital megacolon in transgenic mice that overexpress the Hoxa‐4 gene. Dev Dyn1993;198:28. CrossRef

89. WangH, HughesI, PlanerW, et al.The timing and location of glial cell line‐derived neurotrophic factor expression determine enteric nervous system structure and function. J Neurosci2010;30:1523. CrossRef

90. SasselliV, BoesmansW, Vanden BergheP, et al.Planar cell polarity genes control the connectivity of enteric neurons. JClinInvestig2013;123:1763.

91. GershonMD. Genes and lineages in the formation of the enteric nervous system. Curr Opin Neurobiol1997;7:101. CrossRef

92. GershonMD. V. Genes, lineages, and tissue interactions in the development of the enteric nervous system. Am J Physiol1998;275:G869.

93. ChalazonitisA, RothmanTP, ChenJ, et al.Neurotrophin‐3 induces neural crest‐derived cells from fetal rat gut to develop in vitro as neurons or glia. J Neurosci1994;14:6571.

94. FariñasI, JonesKR, BackusC, et al.Severe sensory and sympathetic deficits in mice lacking neurotrophin‐3. Nature1994;369:658. CrossRef

95. BlaugrundE, PhamTD, TennysonVM, et al.Distinct subpopulations of enteric neuronal progenitors defined by time of development, sympathoadrenal lineage markers, and Mash‐1‐dependence. Development1996;122:309.

96. PichelJG, ShenL, ShengHZ, et al.Defects in enteric innervation and kidney development in mice lacking GDNF. Nature1996;382:73. CrossRef

97. SénchezM, Silos‐SantiagoI, FrisénJ, et al.Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature1996;382:70. CrossRef

98. SchuchardtA, D'AgatiV, Larsson‐BlombergL, et al.Defect in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature1994;367:380. CrossRef

99. ChalazonitisA, RothmanTP, GershonMD. Age‐ and cell type‐dependence of the responses of crest‐derived cells immunoselected from the fetal rat gut to GDNF and NT‐3. Neuroscience1997;23:1430.

100. HearnCJ, MurphyM, NewgreenD. GDNF and ET‐3 differentially modulate the numbers of avian enteric neural crest cells and enteric neurons in vitro. Dev Biol1998;197:93. CrossRef

101. BondurandN, Dastot‐Le MoalF, StanchinaL, et al.Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet2007;81:1169. CrossRef

102. ComijnJ, BerxG, VermassenP, et al.The two‐handed E box binding zinc finger protein SIP1 downregulates E‐cadherin and induces invasion. Mol Cell2001;7:1267. CrossRef

103. StanchinaL, Van de PutteT, GoossensM, et al.Genetic interaction between Sox10 and Zfhx1b during enteric nervous system development. Dev Biol2010;341:416. CrossRef

104. Fiorica‐HowellsE, MaroteauxL, GershonMD. 5‐HT2B receptors mediate the 5‐HT–induced development of enteric neurons. Neuroscience1997;23:1686.

105. HosodaK, HammerRE, RichardsonJA, et al.Targeted and natural (piebald‐lethal) mutation of endothelin‐B receptor produce megacolon associated with spotted coat color in mice. Cell1994;79:1267. CrossRef

106. PuffenbergerEG, HosodaK, WashingtonSS, et al.A missense mutation of the endothelin‐receptor gene in mutagenic Hirschsprung disease. Cell1994;79:1257. CrossRef

107. MitrosFA, SchufflerMD, TejaK, et al.Pathologic features of familial visceral myopathy. Hum Pathol1982;13:825. CrossRef

108. SmithBF. The Neuropathology of the Alimentary Tract. London: Edward Arnold; 1972.

109. SchufflerMD, JonakZ. Chronic idiopathic intestinal pseudoobstruction caused by a degenerative disorder of the myenteric plexus: the use of Smith's method to define the neuropathology. Gastroenterology1982;82:476.

110. SchemannM, CamilleriM. Functions and imaging of mast cell and neural axis of the gut. Gastroenterology2013;144:698. CrossRef

111. WallaceDC. Mitochondrial diseases in man and mouse. Science1999;283:1482. CrossRef

112. MuellerLA, CamilleriM, Emslie‐SmithAM. Mitochondrial neuro‐gastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology1999;116:959. CrossRef

113. Perez‐AtaydeAR, FoxV, TeitelbaumJE, et al.Mitochondrial neurogastrointestinal encephalo‐myopathy: diagnosis by rectal biopsy. Am J Surg Pathol1998;22:1141. CrossRef

114. NishinoI, SpinazzolaA, HiranoM. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science1999;283:689. CrossRef

115. MillaPJ. Endothelins, pseudo‐obstruction and Hirschsprung disease. Gut1999;44:148. CrossRef

116. CarlomagnoF, De VitaG, BerlingieriMT, et al.Molecular heterogeneity of RET loss of function in Hirschsprung disease. EMBO J1996;15:2717.

117. IvanchukSM, MyersSM, EngC, et al.De novo mutation of GDNF, ligand for the RET/GDNF‐alpha receptor complex in Hirschsprung disease. Hum Mol Genet1996;5:2020. CrossRef

118. EderyP, AttieT, AmielJ, et al.Mutation of the endothelin‐3 gene in the Waardenburg‐Hirschsprung disease (Shah‐Waardenburg syndrome). Nat Genet1996;12:442. CrossRef

119. GorlinRJ, SedanoHO, VickersRA, et al.Multiple mucosal neuromas, phaeochromocytoma and medullary carcinoma of the thyroid‐syndrome. Cancer1968;22:293. CrossRef

120. CarneyJA, GoVL, SizemoreGW, et al.Alimentary tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia type 2b. N Engl J Med1976;295:1287. CrossRef

121. EngC, PonderBAJ. Multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. In: Grossman A(ed). Clinical Endocrinology. Oxford, UK: Blackwell Science; 1998: 635.

122. EngC, ClaytonD, SchuffeneckerI, et al.The relationship between specific RET proto‐oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: international RET Mutation Consortium analysis. JAMA1996;276:1575. CrossRef

123. GimmO, MarshDJ, AndrewSD, et al.Germline dinucleotide mutation in codon 883 of the RET proto‐oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab1997;82:3902. CrossRef

124. SongyangZ, CarrawayKLIII, EckMJ, et al.Catalytic specificity of protein‐tyrosine kinases is critical for selective signaling. Nature1995;373:536. CrossRef

125. SantoroM, CarlomangnoF, RomanoA, et al.Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science1995;267:381. CrossRef

126. SmithVV, EngC, MillaPJ. Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment. Gut1999;45:143. CrossRef

127. BonsibSM, FallonB, MitrosFA, et al.Urologic manifestations of patients with visceral myopathy. J Urol1984;132:1112.

128. MurleyRS. Painful enteromegaly of unknown aetiology. Proc R Soc Med1959;52:479.

129. PaulCA, TomiyasuU, MellinkoffSM. Nearly fatal pseudoobstruction of the small intestine. A case report of its relief by subtotal resection of the small bowel. Gastroenterology1961;40:498.

130. NaishJM, CapperWM, BrownNJ. Intestinal pseudoobstruction with steatorrhea. Gut1960;1:62. CrossRef

131. SmithJA, HauserSC, MadaraJL. Hollow visceral myopathy. Am J Surg Pathol1982;6:269. CrossRef

132. SmoutAJPM, De WildeK, KooymanCD, et al.Chronic idiopathic intestinal pseudoobstruction: coexistence of smooth muscle and neuronal abnormalities. Dig Dis Sci1985;30:282. CrossRef

133. BeightonPH, MurdochJL, VottelerT. Gastrointestinal complications of the Ehlers‐Danlos syndrome. Gut1969;10:1004. CrossRef

134. DouglasBS, DouglasHM. Rectal prolapse in the Ehlers‐Danlos syndrome. Aust Paediatr J1973;9:109.

135. SatoT, ItoH, MiyazakiS, et al.Megacystis and megacolon in an infant with Ehlers‐Danlos syndrome. Acta Paediatr Jpn1993;35:358. CrossRef

136. BlakerH, FunkeB, HausserI, et al.Pathology of the large intestine in patients with vascular type Ehlers‐Danlos syndrome. Virchows Arch2007;450:713. CrossRef

137. ReinsteinE, PimentelM, ParianiM, et al.Visceroptosis of the bowel in the hypermobility type of Ehlers‐Danlos syndrome: presentation of a rare manifestation and review of the literature. Eur J Med Genet2012;55:548. CrossRef

138. RhodesJB, RobinsonRG, McBrideN. Sudden onset of slow gastric emptying of food. Gastroenterology1979;77:569.

139. MeeroffJC, SchreiberDS, TrierJS, et al.Abnormal gastric motor function in gastroenteritis. Ann Intern Med1980;92:370. CrossRef

140. DyerNH, DawsonAM, SmithBF, et al.Obstruction of bowel due to lesion in the myenteric plexus. Br Med J1969;1:686. CrossRef

141. ShilkinKB, GraceyM, JoskeRA. Idiopathic intestinal pseudoobstruction. Report of a case with neuropathological studies. Aust Paediatr J1978;14:102.

142. BogomoletzWV, BirembautP, GaillardD, et al.Chronic idiopathic intestinal pseudoobstruction with myenteric plexus damage. Lancet1979;1:679. CrossRef

143. HanksJB, MeyersWC, AndersenDK, et al.Chronic primary intestinal pseudoobstruction. Surgery1981;89:175.

144. AchemSR, OwyangC, SchufflerMD, et al.Neuronal dysplasia and chronic intestinal pseudoobstruction: rectal biopsy as a possible aid to diagnosis. Gastroenterology1987;92:805.

145. NahaiF. Pseudoobstruction of the small bowel. Bristol Med Chir J1969;84:209.

146. SchufflerMD, RohrmannCAJr, TempletonFE. The radiologic manifestations of idiopathic intestinal pseudoobstruction. Am J Roentgenol Radium Ther Nucl Med1976;127:729. CrossRef

147. KrishnamurthyS, HengY, SchufflerMD. Chronic intestinal pseudoobstruction in twenty‐six infants and young children caused by a spectrum of abnormalities of the myenteric plexus. Gastroenterology1992;102:A471.

148. StanghelliniV, CamilleriM, MalageladaJ‐R. Chronic idiopathic intestinal pseudo‐obstruction: clinical and intestinal manometric findings. Gut1987;28:5. CrossRef

149. HymanPE, NapolitanoJA, DiegoA, et al.Antroduodenal manometry in the evaluation of chronic functional gastrointestinal symptoms. Pediatrics1990;86:39.

150. MossAA, GoldbergHI, BrotmanM. Idiopathic intestinal pseudoobstruction. Am J Roentgenol Radium Ther Nucl Med1972;115:312. CrossRef

151. LukieBE, SandersMG. Chronic idiopathic intestinal pseudoobstruction with malabsorption, a scleroderma‐like disorder. Can Med Assoc J1973;109:1222.

152. KeshavarzianA, IsaacsP, McCollI, et al.Idiopathic intestinal pseudoobstruction and contaminated small bowel syndrome—treatment with metronidazole, ileostomy and indomethacin. Am J Gastroenterol1983;78:562.

153. StanghelliniV, CogliandroRF, De GiorgioR, et al.Natural history of chronic idiopathic intestinal pseudo‐obstruction in adults: a single center study. Clin Gastroenterol Hepatol2005;3:449. CrossRef

154. De GiorgioR, SarnelliG, CorinaldesiR, et al.Advances in our understanding of the pathology of chronic intestinal pseudo‐obstruction. Gut2004;53:1549. CrossRef

155. De GiorgioR, VoltaU, StanghelliniV, et al.Neurogenic chronic intestinal pseudo‐obstruction: antineuronal antibody‐mediated activation of autophagy via Fas. Gastroenterology2008;135:601. CrossRef

156. KellowJE, PhillipsSF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology1987;92:1885.

157. ThompsonDG, LaidlowJM, WingateDL. Abnormal small bowel motility demonstrated by radiotelemetry in a patient with irritable colon. Lancet1979;2:1321. CrossRef

158. SummersRW, AnurasS, GreenJ. Jejunal manometry patterns in health, partial intestinal obstruction, and pseudo‐obstruction. Gastroenterology1983;85:1290.

159. CamilleriM, BrownML, MalageladaJ‐R. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology1986;91:619.

160. NullensS, NelsenT, CamilleriM, et al.Regional colon transit in patients with dyssynergic defecation or slow transit in patients with constipation. Gut2012;61:1132. CrossRef

161. HoskinsLC, NorrisHT, GottliebLS, et al.Functional and morphological alterations of the gastrointestinal tract in progressive systemic sclerosis (scleroderma). Am J Med1962;33:459. CrossRef

162. BluestoneR, MacMahonM, DawsonJM. Systemic sclerosis and small bowel involvement. Gut1969;10:185. CrossRef

163. PoirierTJ, RankinGB. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol1972;58:30.

164. CohenS, LauferI, SnapeWJJr. The gastrointestinal manifestation of scleroderma: pathogenesis and management. Gastroenterology1980;79:155.

165. NeefB, KirschH, AndusT. Image of the month: "hide‐bound" bowel sign in scleroderma. Gastroenterology2003;124:1179, 1567. CrossRef

166. QuelozJM, WoloshinHJ. Sacculation of the small intestine in scleroderma. Radiology1972;105:513. CrossRef

167. KawaguchiY, NakamuraY, MatsumotoI, et al.Muscarinic‐3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility. Ann Rheum Dis2009;68:710. CrossRef

168. GoldblattF, GordonTP, WatermanSA. Antibody‐mediated gastrointestinal dysmotility in scleroderma. Gastroenterology2002;123:1144. CrossRef

169. SchufflerMD, BeagleRG. Progressive systemic sclerosis of the gastrointestinal tract and hereditary hollow visceral myopathy: two distinguishable disorders of intestinal smooth muscle. Gastroenterology1979;77:664.

170. D'AngeloWA, FriesJF, MasiAST, et al.Pathologic observations in systemic sclerosis (scleroderma): a study of fifty‐eight matched controls. Am J Med1969;46:428. CrossRef

171. ArcillaR, BandlerM, MortonF, et al.Gastrointestinal scleroderma simulating chronic and acute intestinal obstruction. Gastroenterology1956;31:764.

172. TreacyWL, BuntingWL, GambillEE, et al.Scleroderma presenting as obstruction of the small bowel. Proc Staff Meet Mayo Clin1962;37:607.

173. MiercortCD, MerrillFG. Pneumatosis and pseudoobstruction in scleroderma. Radiology1969;92:359. CrossRef

174. HirshEH, BradenburgD, HershT, et al.Chronic intestinal pseudoobstruction. J Clin Gastroenterol1981;3:247. CrossRef

175. ReesWDW, LeighRJ, ChristofidesND, et al.Interdigestive motor activity in patients with systemic sclerosis. Gastroenterology1982;83:575.

176. SoudahHC, HaslerWL, OwyangC. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med1991;325:1461. CrossRef

177. GreydanusMP, CamilleriM, ColemontLJ, et al.Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology1990;99:158.

178. Di CiaulaA, CovelliM, BerardinoM, et al.Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma. BMC Gastroenterol2008;8:7. CrossRef

179. BortolottiM, TurbaE, TostiA, et al.Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma. Am J Gastroenterol1991;86:743.

180. WestonS, ThumshirnM, WisteJ, et al.Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol1998;93:1085. CrossRef

181. MadsenJL, HendelL. Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis. Dig Dis Sci1992;37:1404. CrossRef

182. FiorucciS, DistruttiE, BassottiG, et al.Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients. Scand J Gastroenterol1994;29:807. CrossRef

183. Foxx‐OrensteinA, CamilleriM, StephensD, et al.Effect of somatostatin analog on gastric motor and sensory functions in healthy humans. Gut2003;52:1555. CrossRef

184. KlecknerFS. Dermatomyositis and its manifestations in the gastrointestinal tract. Am J Gastroenterol1970;53:141.

185. FeldmanF, MarshakRH. Dermatomyositis with significant involvement of the gastrointestinal tract. Am J Roentgenol1963;90:746.

186. MalkinsonFD, RothmanS. Changes in the gastrointestinal tract in scleroderma and other diffuse connective tissue diseases. Am J Gastroenterol1956;26:414.

187. SwensonWM, WitkowskiLJ, RoskelleyRC. Total colectomy for dermatomyositis. Am J Surg1968;115:405. CrossRef

188. Tweezer‐ZaksN, Ben‐HorinS, SchibyG, et al.Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association. AmJMedSci2006;332:308.

189. HoffmanBI, KatzWA. The gastrointestinal manifestations of systemic lupus erythematosus: a review of the literature. Semin Arthritis Rheum1980;9:237. CrossRef

190. BrownCH, ShireyEK, HaserickJR. Gastrointestinal manifestations of systemic lupus erythematosus. Gastroenterology1956;31:364.

191. ShapeeroLG, MyersA, OberkircherPE, et al.Acute reversible lupus vasculitis of the gastrointestinal tract. Radiology1974;112:569. CrossRef

192. KishimotoM, NasirA, MorA, et al.Acute gastrointestinal distress syndrome in patients with systemic lupus erythematosus. Lupus2007;16:137. CrossRef

193. DubrowMH, McPhersonJR, BowieJW. Lupus erythematosus presenting as an acute abdomen. Minn Med1966;49:577.

194. ShaferRB, GregoryDH. Systemic lupus erythematosus presenting as regional enteritis. Minn Med1970;53:789.

195. WeiserMM, AndresGA, BrentjensJR, et al.Systemic lupus erythematosus and intestinal venulitis. Gastroenterology1981;81:570.

196. NormanDA, FleischmannRM. Gastrointestinal systemic sclerosis in serologic mixed connective tissue disease. Arthritis Rheum1978;21:811. CrossRef

197. CamilleriM, MalageladaJR. Abnormal intestinal motility in diabetics with gastroparesis. Eur J Clin Invest1984;14:427. CrossRef

198. DooleyCP, El NewihiHM, ZeidlerA, et al.Abnormalities of the migrating motor complex in diabetics with autonomic neuropathy and diarrhea. Scand J Gastroenterol1988;23:217. CrossRef

199. KeshavarzianA, IberFL. Intestinal transit in insulin‐dependent diabetes mellitus. Am J Gastroenterol1986;81:257.

200. ScarpelloHJB, GreavesM, SladenGE. Small intestinal transit in diabetes. Br Med J1976;2:1225. CrossRef

201. CamilleriM, MalageladaJ‐R. Abnormal intestinal motility in diabetics with gastroparesis syndrome. Eur J Clin Invest1984;14:420. CrossRef

202. SmithHB. Neuropathology of the esophagus in diabetes mellitus. J Neurol Neurosurg Psychiatry1974;37:1155. CrossRef

203. WhalenGE, SoergelKH, GeenenJE. Diabetic diarrhea. A clinical and pathophysiological study. Gastroenterology1969;56:1021.

204. HeCL, SofferEE, FerrisCD, et al.Loss of interstitial cells of cajal and inhibitory innervation in insulin‐dependent diabetes. Gastroenterology2001;121:427. CrossRef

205. MalageladaJR, ReesWDW, MazzottaLJ, et al.Gastric motor abnormalities in diabetic and post‐vagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology1980;78:286.

206. HorowitzM, HardingPE, ChattertonBE, et al.Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci1985;30:1. CrossRef

207. Achem‐KaramSR, FunkcoshiA, VinikAI, et al.Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: effect of metoclopramide. Gastroenterology1985;88:492.

208. BjornssonES, UrbanaviciusV, EliassonB, et al.Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol1994;29:1096. CrossRef

209. MalekiD, LockeGRIII, CamilleriM, et al.Gastrointestinal symptoms among persons with diabetes in the community. Arch Intern Med2000;160:2808. CrossRef

210. JanatuinenE, PikkarainenP, LaaksoM, et al.Gastrointestinal symptoms in middle‐aged diabetic patients. Scand J Gastroenterol1993;28:427. CrossRef

211. MalekiD, CamilleriM, BurtonDD, et al.Pilot study of pathophysiology of constipation among community diabetics. Dig Dis Sci1998;43:2373. CrossRef

212. MalekiD, CamilleriM, ZinsmeisterAR, et al.Effect of acute hyperglycemia on colorectal motor and sensory function in humans. Am J Physiol1997;273:G859.

213. EdwardsLL, PfeifferRF, QuigleyEMM, et al.Gastrointestinal symptoms in Parkinson's disease. Mov Disord1991;6:151. CrossRef

214. LewitanA, NathansonL, SladeWR. Megacolon and dilation of the small bowel in parkinsonism. Gastroenterology1952;17:367.

215. BozemanT, AnurasS, HuttonT, et al.Small intestinal manometry in Parkinson's disease. Gastroenterology1990;99:1202.

216. QualmanSJ, HauptHM, YangP, et al.Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology1984;87:848.

217. KupskyWJ, GrimesMM, SweetingJ, et al.Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology1987;37:1253. CrossRef

218. Da Costa DiasB, JovanovicK, WeissSF. Alimentary prion infections: touchdown in the intestine. Prion2011;5:6. CrossRef

219. Lema ToméCM, TysonT, ReyNL, et al.Inflammation and α‐synuclein's prion‐like behavior in Parkinson's disease–is there a link?Mol Neurobiol2013;47:561. CrossRef

220. JostWH, EckardtVF. Constipation in idiopathic Parkinson's disease. Scand J Gastroenterol2003;38:681.

221. KayeJ, GageH, KimberA, et al.Excess burden of constipation in Parkinson's disease: a pilot study. Mov Disord2006;21:1270. CrossRef

222. SingaramC, AshrafW, GaumnitzEA, et al.Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet1995;346:861. CrossRef

223. WakabayashiK, TakahashiH, OhamaE, et al.Parkinson's disease: an immunohistochemical study of Lewy body‐containing neurons in the enteric nervous system. Acta Neuropathol1990;79:581. CrossRef

224. CersosimoMG, BenarrochEE. Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord2008;23:1065. CrossRef

225. ChenCY, ChuangTY, TsaiYA, et al.Loss of sympathetic coordination appears to delay gastrointestinal transit in patients with spinal cord injury. DigDisSci2004;49:738.

226. GondimFA, RodriguesCL, da GracaJR, et al.Neural mechanisms involved in the delay of gastric emptying and gastrointestinal transit of liquid after thoracic spinal cord transection in awake rats. Auton Neurosci2001;87:52. CrossRef

227. KabatasS, YuD, HeXD, et al.Neural and anatomical abnormalities of the gastrointestinal system resulting from contusion spinal cord injury. Neuroscience2008;154:1627. CrossRef

228. FealeyRD, SzurszewskiJH, MerittJL, et al.Effect of spinal cord transection on human upper gastrointestinal motility and gastric emptying. Gastroenterology1984;87:69.

229. NgC, ProttG, RutkowskiS, et al.Gastrointestinal symptoms in spinal cord injury: relationships with level of injury and psychologic factors. Dis Colon Rectum2005;48:1562. CrossRef

230. FajardoNR, PasiliaoRV, Modeste‐DuncanR, et al.Decreased colonic motility in persons with chronic spinal cord injury. Am J Gastroenterol2003;98:128. CrossRef

231. EbertE. Gastrointestinal involvement in spinal cord injury: a clinical perspective. J Gastrointest Liver Dis2012;21:75.

232. MarshakRH, FreundS, MaklanskyD. Neurofibromatosis of the small bowel. Am J Dig Dis1963;8:478. CrossRef

233. DavisGB, BerkRN. Intestinal neurofibromas in von Recklinghausen's disease. Am J Gastroenterol1973;60:410.

234. FeinstatT, TeslukH, SchufflerMD, et al.Megacolon and neurofibromatosis. A neuronal intestinal dysplasia. Gastroenterology1984;86:1573.

235. HanemannCO, HaywardC, HiltonDA. Neurofibromatosis type 1 with involvement ofthe enteric nerves. J Neurol Neurosurg Psychiatry2007;78:1163. CrossRef

236. ChiappaKH, YoungRR. A case of paracarcinomatous pandysautonomia. Neurology1973;23:423.

237. AhmedMN, CarpenterS. Autonomic neuropathy and carcinoma of the lung. Can Med Assoc J1975;113:410.

238. SchufflerMD, BairdHW, FlemingCR, et al.Intestinal pseudoobstruction as the presenting manifestation of small‐cell carcinoma of the lung. Ann Intern Med1983;98:129. CrossRef

239. SodhiN, CamilleriM, CamorianoJK, et al.Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci1989;34:1937. CrossRef

240. LennonVA, SasDF, BuskMF, et al.Enteric neuronal autoantibodies in pseudoobstruction with small‐cell lung carcinoma. Gastroenterology1991;100:137.

241. ChinnJS, SchufflerMD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology1988;95:1279.

242. LeeH‐R, LennonVA, CamilleriM, et al.Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol2001;96:373. CrossRef

243. KullingD, ReedCE, VerneGN, et al.Intestinal pseudo‐obstruction as a paraneoplastic manifestation of malignant thymoma. Am J Gastroenterol1997;2:1564.

244. LhermitteF, GrayF, Lyon‐CaenO, et al.Paralysis of digestive tract with lesions of myenteric plexus: a new paraneoplastic syndrome. Rev Neurol (Paris) 1980;136:825.

245. SuttonI, WinerJ, RowlandsD, et al.Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer. J Neurol Neurosurg Psychiatry2000;69:266. CrossRef

246. DrukkerCA, HeijHA, WijnaendtsLC, et al.Paraneoplastic gastro‐intestinal anti‐Hu syndrome in neuroblastoma. Pediatr Blood Cancer2009;52:396. CrossRef

247. PardiDS, MillerSM, MillerDL, et al.Paraneoplastic dysmotility: loss of interstitial cells of Cajal. Am J Gastroenterol2002;97:1828. CrossRef

248. OlofssonBO, NiklassonU, ForsbergH, et al.Assessment of autonomic nerve function in myotonic dystrophy. J Auton Nerv Syst1990;29:187. CrossRef

249. ChiuVSW, EnglertE. Gastrointestinal disturbances in myotonia dystrophica. Gastroenterology1962;42:745.

250. LupsS. Dystrophia myotonica with steatorrhea. Acta Med Scand1941;106:557. CrossRef

251. KempA. Some metabolic aspects of myotonia dystrophica. Folia Psychiatr Neurol Neurochir Neerl1957;60:88.

252. TielemanAA, van VlietJ, JansenJB, et al.Gastrointestinal involvement is frequent in myotonic dystrophy type 2. Neuromuscul Disord2008;18:646. CrossRef

253. HarveyJC, SherbourneDH, SiegelCI. Smooth muscle involvement in myotonic dystrophy. Am J Med1965;39:81. CrossRef

254. LewisTD, DanielEE. Gastroduodenal motility in a case of dystrophia myotonica. Gastroenterology1981;81:145.

255. SimpsonAF, KhilnaniMT. Gastrointestinal manifestations of the muscular dystrophies. Am J Roentgenol1975;125:948. CrossRef

256. NowakTV, AnurasS, BrownBP. Small intestinal motility in myotonic dystrophy patients. Gastroenterology1984;86:808.

257. PruzanskiW, HuvosAG. Smooth muscle involvement in primary muscle disease. Arch Pathol1967;83:229.

258. KeschnerM, DavisonD. Dystrophica myotonica: a clinicopathologic study. Arch Neurol Psychiatr1933;30:1259. CrossRef

259. YoshidaMM, KrishnamurthyS, WattchowDA. Megacolon in myotonic dystrophy caused by a degenerative neuropathy of the myenteric plexus. Gastroenterology1988;95:820.

260. BevansM. Changes in the musculature of the gastrointestinal tract and in the myocardium in progressive muscular dystrophy. Arch Pathol1945;40:225.

261. JaffeKM, McDonaldCM, IngmanE, et al.Symptoms of upper gastrointestinal dysfunction in Duchenne muscular dystrophy: case‐control study. Arch Phys Med Rehabil1990;71:742.

262. VannucchiMG, CorsaniL, GiovanniniMG, et al.Expression of dystrophin in the mouse myenteric neurones. Neurosci Lett2001;300:120. CrossRef

263. VannucchiMG, CorsaniL, Faussone‐PellegriniMS. Synaptic vesicle morphology and recycling are altered in myenteric neurons of mice lacking dystrophin. J Cell Physiol2003;197:232. CrossRef

264. PaneM, VastaI, MessinaS, et al.Feeding problems and weight gain in Duchenne muscular dystrophy. Eur J Paediatr Neurol2006;10:231. CrossRef

265. KormanSH, Bar‐OzB, GranotE, et al.Orocaecal transit time in Duchenne muscular dystrophy. Arch Dis Child1991;66:143. CrossRef

266. CroweGG. Acute dilatation of stomach as a complication of muscular dystrophy. Br Med J1961;1:1371. CrossRef

267. RobinGC, De la FalewskiG. Acute gastric dilatation in progressive muscular dystrophy. Lancet1963;2:171. CrossRef

268. BarohnRJ, LevineEJ, OlsonJO, et al.Gastric hypomotility in Duchenne's muscular dystrophy. N Engl J Med1988;319:15. CrossRef

269. LeonSH, SchufflerMD, KettlerM, et al.Chronic intestinal pseudoobstruction as a complication of Duchenne's muscular dystrophy. Gastroenterology1986;90:455.

270. GilatT, RevachM, SoharE. Deposition of amyloid in the gastrointestinal tract. Gut1969;10:98. CrossRef

271. GilatT, SpiroHM. Amyloidosis and the gut. Am J Dig Dis1968;13:619. CrossRef

272. MadsenLG, GimsingP, SchiodtFV. Primary (AL) amyloidosis with gastrointestinal involvement. Scand J Gastroenterol2009;44:708. CrossRef

273. FeurleGE. Pathophysiology of diarrhea in patients with familial amyloid neuropathy. Digestion1987;36:13. CrossRef

274. GuirlMJ, HogenauerC, Santa AnaCA, et al.Rapid intestinal transit as a primary cause of severe chronic diarrhea in patients with amyloidosis. Am J Gastroenterol2003;98:2219. CrossRef

275. WaldA, KichlerJ, MendelowH. Amyloidosis and chronic intestinal pseudoobstruction. Dig Dis Sci1981;26:462. CrossRef

276. MitrosFA. Motor and mechanical disorders. In: Ming S, Goldman H(eds). Pathology of the Gastrointestinal Tract. Philadelphia: WB Saunders; 1992: 208.

277. LeggeDA, CarlsonHC, WollaegerEE. Roentgenologic appearance of systemic amyloidosis involving gastrointestinal tract. Am J Roentgenol1970;110:406. CrossRef

278. OliveiraRB, MeneghelliUG, De GodoyRA, et al.Abnormalities of interdigestive motility of the small intestine in patients with Chagas' disease. Dig Dis Sci1983;28:294. CrossRef

279. KeberleF. Enteromegaly and cardiomegaly in Chagas' disease. Gut1963;4:399. CrossRef

280. Sterin‐BordaL, GoinJC, BilderCR, et al.Interaction of human chagasic IgG with human colon muscarinic acetylcholine receptor: molecular and functional evidence. Gut2001;49:699. CrossRef

281. OliveiraEC, FujisawaMM, Hallal LongoDE, et al.Neuropathy of gastrointestinal Chagas' disease: immune response to myelin antigens. Neuroimmunomodulation2009;16:54. CrossRef

282. ShaferR, PrentissR, BondJ. Gastrointestinal transit in thyroid disease. Gastroenterology1984;86:852.

283. MillerL, GormanC, GoV. Gut‐thyroid interrelationships. Gastroenterology1978;75:901.

284. MiddletonW. Thyroid hormones and the gut. Gut1971;12:172. CrossRef

285. ChristensenJH, SchedlH, CliftonJ. The basic electrical rhythm of the duodenum in normal human subjects and in patients with thyroid disease. J Clin Invest1964;43:1659. CrossRef

286. ChristensenJH, CliftonJ, SchedlH. Variations in the frequency of the human duodenal basic electrical rhythm in health and disease. Gastroenterology1966;51:200.

287. ShirerJW. Hypermotility of the gastrointestinal tract in hyperthyroidism. Am J Med Sci1933;186:73. CrossRef

288. BrownRB, PendergrassEP, BurdickED. Hypermotility of the gastrointestinal tract in hyperthyroidism. Surg Gynecol Obstet1941;73:766.

289. WegenerM, WedmannB, LanghoffT, et al.Effect of hyperthyroidism on the transit of a caloric solid‐liquid meal through the stomach, the small intestine, and the colon in man. J Clin Endocrinol Metab1992;75:745.

290. WileyZD, LarigneME, LiuKM, et al.The effect of hyperthyroidism on gastric emptying rates and pancreatic exocrine and biliary secretion in man. Dig Dis Sci1978;23:1008.

291. MillerLJ, OwyangC, MalageladaJR, et al.Gastric, pancreatic and biliary responses to meals in hyperthyroidism. Gut1980;21:695. CrossRef

292. MiddletonWRJ, ThompsonGR. Steatorrhea in hyperthyroidism. Gut1968;9:725. CrossRef

293. ThomasFB, CaldwellJH, GreenbergerNJ. Steatorrhea in thyrotoxicosis. Relation to hypermotility and excessive dietary fat. Ann Intern Med1973;78:669. CrossRef

294. DuretRL, BastenieMD. Intestinal disorders in hypothyroidism. Clinical and manometric study. Am J Dig Dis1971;16:723. CrossRef

295. BasteniePA. Paralytic ileus in severe hypothyroidism. Lancet1946;1:413. CrossRef

296. HohlRD, NixonRK. Myxedema ileus. Arch Intern Med1965;115:145. CrossRef

297. AbbasiAA, DouglassRC, BissellGW, et al.Myxedema ileus. A form of intestinal pseudoobstruction. J Am Med Assoc1975;234:181. CrossRef

298. BoruchowIB, MillerLD, FittsWT. Paralytic ileus in myxedema. Arch Surg1966;92:960. CrossRef

299. SalernoN, GreyN. Myxedema pseudoobstruction. Am J Roentgenol1978;130:175. CrossRef

300. Sategna‐GuidettiC, VoltaU, CiacciC, et al.Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol2001;96:751. CrossRef

301. TaybiH, KeeleD. Hypoparathyroidism: a review of the literature and report of two cases in sisters, one with steatorrhea and intestinal pseudoobstruction. Am J Roentgenol1962;88:432.

302. DavisJT, NusbaumM. Chlorpromazine therapy and functional large bowel obstruction. Am J Gastroenterol1973;60:635.

303. SpiroRK, KysilewskyjRM. Iatrogenic ileus secondary to medication. J Med Soc N J1973;70:565.

304. WarnesH, LehmannHE, BanTA. Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases. Can Med Assoc J1967;96:1112.

305. MilnerG. Gastrointestinal side effects and psychotropic drugs. Med J Aust1969;2:153.

306. PalmerSE, McLeanRM, EllisPM, et al.Life‐threatening clozapine‐induced gastrointestinal hypomotility: an analysis of 102 cases. JClinPsychiatry2008;69:759.

307. TaylorP. Atropine, scopolamine, and related antimuscarinic drugs. In: Gilman AG, Goodman LS, Rall TW, et al. (eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics, 6th edn. New York: Macmillan; 1985: 136.

308. JaffeJH, MartinWR. Opioid analgesics and antagonists. In: Gilman AG, Goodman LS, Rall TW, et al. (eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics, 6th edn. New York: Macmillan; 1985: 503.

309. BurksTF, GalliganJJ, PorrecaF. Gastrointestinal drug receptors. J Clin Gastroenterol1983;5(Suppl 1):29. CrossRef

310. YukiokaH, RosenM, EvansKT, et al.Gastric emptying and small bowel transit times in volunteers after intravenous morphine and nalbuphine. Anaesthesia1987;42:704. CrossRef

311. MaurerAH, KrevskyB, KnightLC, et al.Opioid and opioid‐like drug effects on whole‐gut transit measured by scintigraphy. J Nucl Med1996;37:818.

312. JeongID, CamilleriM, ShinA, et al.A randomised, placebo‐controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Aliment Pharmacol Ther2012;35:1089.

313. KachelG, RuppinH, HagelJ, et al.Human intestinal motor activity and transport: effects of a synthetic opiate. Gastroenterology1986;90:85.

314. BasiliscoG, BozzaniA, CamboniG, et al.Effect of loperamide and naloxone on mouth‐to‐caecum transit time evaluated by lactulose hydrogen breath test. Gut1985;26:200. CrossRef

315. YeeMK, EvansWD, FaceyPE, et al.Gastric emptying and small bowel transit in male volunteers after i.m. ketorolac and morphine. Br J Anaesth1991;67:426. CrossRef

316. KrevskyB, MaurerAH, NiewiarowskiT, et al.Effect of verapamil on human intestinal transit. Dig Dis Sci1992;37:919. CrossRef

317. RubinoffMJ, PiccionePR, HoltPR. Clonidine prolongs human small intestine transit time: use of lactulose‐breath hydrogen test. Am J Gastroenterol1989;84:36.

318. ViramontesB, MalcolmA, SzarkaL, et al.Dose‐related effects of α2‐adrenergic agent, clonidine, on human gastrointestinal motor, transit and sensory functions. Gastroenterology2000;118:A666. CrossRef

319. FedorakRN, FieldM, ChangEB. Treatment of diabetic diarrhea with clonidine. Ann Intern Med1985;102:197. CrossRef

320. JanssensJ, PeetersTL, Van TrappenG, et al.Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med1990;322:1028. CrossRef

321. TaylorP. Cholinergic agonists. In: Gilman AG, Goodman LS, Rall TW, et al. (eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics, 6th edn. New York: Macmillan; 1985: 103.

322. PratherCM, CamilleriM, ZinsmeisterAR, et al.Tegaserod accelerates orocecal transit in patients with constipation‐predominant irritable bowel syndrome. Gastroenterology2000;118:463. CrossRef

323. ColeskiR, OwyangC, HaslerWL. Modulation of intestinal gas dynamics in healthy human volunteers by the 5‐HT receptor agonist tegaserod. Am J Gastroenterol2006;101:1858. CrossRef

324. HarumaK, WisteJA, CamilleriM. Effect of octreotide on gastrointestinal pressure profiles in health, functional and organic gastrointestinal disorders. Gut1994;35:1064. CrossRef

325. VerneGN, EakerEY, HardyE, et al.Effect of octreotide and erythromycin on idiopathic and scleroderma‐associated intestinal pseudo‐obstruction. Dig Dis Sci1995;40:1892. CrossRef

326. Von der OheMR, CamilleriM, ThomfordeGM, et al.Differential regional effects of octreotide on human gastrointestinal motor function. Gut1995;36:743. CrossRef

327. IngelfingerFJ. The diagnosis of sprue in non‐tropical areas. N Engl J Med1963;228:180. CrossRef

328. DawsonDJ, SciberrasCM, WhitwellH. Coeliac disease presenting with intestinal pseudoobstruction. Gut1984;25:1003. CrossRef

329. Anon. Case Records of the Massachusetts General Hospital. Abdominal pain and vomiting in a 64‐year‐old man with chronic malabsorption and diarrhea. N Engl J Med1990;322:1796. CrossRef

330. NelsonPA, SchmitzRL, NarseteEM. Jejunal diverticulosis complicated by chronic “non‐mechanical” obstruction. Ill Med J1954;106:371.

331. KongaraKR, SofferEE. Intestinal motility in small bowel diverticulosis: a case report and review of the literature. J Clin Gastroenterol2000;30:84. CrossRef

332. KrishnamurthyS, KellyMM, RohrmannCA, et al.Jejunal diverticulosis. Gastroenterology1983;85:538.

333. SummersRW, FlattAJ, PrihodaM, et al.Small intestinal motility in dogs after irradiation injury. Dig Dis Sci1987;32:1402. CrossRef

334. OttersonMF, SarnaSK, MoulderJE. Effects of fractionated doses of ionizing radiation on small intestinal motor activity. Gastroenterology1988;95:1249.

335. OttersonMF, SarnaSK, LeeMB. Fractionated doses of ionizing radiation after postprandial small intestinal motor activity. Dig Dis Sci1992;37:709. CrossRef

336. SummersRW, GlennCE, FlattAJ, et al.Does irradiation produce irreversible changes in canine jejunal myoelectric activity?Dig Dis Sci1992;37:716. CrossRef

337. Fernandez‐BanaresF, VillaS, EsteveM, et al.Acute effects of abdominopelvic irradiation on the orocecal transit time: its relation to clinical symptoms and bile salt and lactose malabsorption. Am J Gastroenterol1991;86:1771.

338. NovakJM, CollinsJT, DonowitzM, et al.Effects of radiation on human intestinal tract. J Clin Gastroenterol1979;1:9. CrossRef

339. WarrenS, FriedmanNB. Pathology and pathologic diagnosis of radiation lesions in the gastrointestinal tract. Am J Pathol1942;18:499.

340. SchierJ, SymmondsRF, DahlinDC. Clinicopathologic aspects of actinic enteritis. Surg Gynecol Obstet1964;199:1019.

341. PerinoLE, SchufflerMD, MehtaSJ, et al.Radiation‐induced recurrent intestinal pseudoobstruction. Gastroenterology1986;91:994.

342. HatoumOA, BinionDG, PhillipsSA, et al.Radiation induced small bowel "web" formation is associated with acquired microvascular dysfunction. Gut2005;54:1797. CrossRef

343. McDonaldGB, SchufflerMD, KadinME, et al.Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine. Gastroenterology1985;89:882.

344. WinsteadNS, WillardSG. Gastrointestinal complaints in patients with eating disorders. J Clin Gastroenterol2006;40:678. CrossRef

345. BoydC, AbrahamS, KellowJ. Psychological features are important predictors of functional gastrointestinal disorders in patients with eating disorders. Scand J Gastroenterol2005;40:929. CrossRef

346. HirakawaM, OkadaT, IidaM, et al.Small bowel transit time measured by hydrogen breath test in patients with anorexia nervosa. Dig Dis Sci1990;35:733. CrossRef

347. KamalN, ChamiT, AndersenA, et al.Delayed gastrointestinal transit times in anorexia nervosa and bulimia nervosa. Gastroenterology1991;101:1320.

348. BeniniL, TodescoT, Dalle GraveR, et al.Gastric emptying in patients with restricting and binge/purging subtypes of anorexia nervosa. Am J Gastroenterol2004;99:1448. CrossRef

349. VantrappenG, JanssensJ, HellemansJ, et al.The interdigestive motor complex of normal subjects and patients with bacteria overgrowth of the small intestine. J Clin Invest1977;59:1158. CrossRef

350. AttarA, FlourieB, RambaudJC, et al.Antibiotic efficacy in small intestinal bacterial overgrowth‐related chronic diarrhea: a crossover, randomized trial. Gastroenterology1999;117:794. CrossRef

351. VijayakanthanN, DhamanaskarK, StewartL, et al.A review of pneumatosis intestinalis in the setting of systemic cancer treatments, including tyrosine kinase inhibitors. Can Assoc Radiol J2012;63:312. CrossRef

352. KimMJ, KimYJ, LeeJH, et al.Norovirus: a possible cause of pneumatosis intestinalis. JPediatr Gastroenterol Nutr2011;52:314. CrossRef

353. SagaraA, KitagawaK, FuruichiK, et al.Three cases of pneumatosis intestinalis presenting in autoimmune diseases. Mod Rheumatol2012;22:610. CrossRef

354. VendryesC, HunterCJ, HarlanSR, et al.Pneumatosis intestinalis after laparoscopic appendectomy: case report and review of the literature. J Pediatr Surg2011;46:e21. CrossRef

355. ShandAG, PenmanID, GhoshS. Effects of a controlled challenge of chloral hydrate in pneumatosis cystoides coli–further evidence of a causal link?Am J Gastroenterol2000;95:3654.

356. KhalilPN, Huber‐WagnerS, LadurnerR, et al.Natural history, clinical pattern, and surgical considerations of pneumatosis intestinalis. Eur J Med Res2009;14:231. CrossRef

357. VillaltaD, ImbastaroT, Di GiovanniS, et al.Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis. Autoimmun Rev2012;12:114. CrossRef

358. MillerRE, SellinkJL. Enteroclysis: the small bowel enema. Radiology1979;4:269.

359. PaulsenSR, HuprichJE, FletcherJG, et al.CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics2006;26:641. CrossRef

360. MerlinA, SoyerP, BoudiafM, et al.Chronic intestinal pseudo‐obstruction in adult patients: multidetector row helical CT features. Eur Radiol2008;18:1587. CrossRef

361. HintonJM, Lennard‐JonesJE, YoungAC. A new method for studying gut transit times using radiopaque markers. Gut1969;10:842. CrossRef

362. MartelliH, DevroedeG, ArhanP. Some parameters of large bowel motility in normal man. Gastroenterology1978;75:612.

363. MartelliH, DevroedeG, ArhanP, et al.Mechanisms of idiopathic constipation: outlet obstruction. Gastroenterology1978;75:623.

364. ArhanP, DevroedeG, JehanninB, et al.Segmental colonic transit time. Dis Colon Rectum1981;24:625. CrossRef

365. MetcalfAM, PhillipsSF, ZinsmeisterAR, et al.Simplified assessment of segmental colonic transit. Gastroenterology1987;92:40.

366. ProanoM, CamilleriM, PhillipsSF, et al.Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol1990;258:G856.

367. O'DonnellLJD, VirjeeJ, HeatonKW. Detection of pseudodiarrhea by simple clinical assessment of intestinal transit rates. Br Med J1990;300:439. CrossRef

368. HammerJ, PhillipsSF. Fluid loading of the human colon: effects of segmental transit and stool composition. Gastroenterology1993;105:988.

369. DegenL, PhillipsSF. How well does stool form reflect colonic transit?Gut1996;39:109. CrossRef

370. KuoB, McCallumRW, KochKL, et al.Comparison of gastric emptying of a nondigestible capsule to a radio‐labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther2008;27:186. CrossRef

371. CassillyD, KantorS, KnightLC, et al.Gastric emptying of a non‐digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil2008;20:311. CrossRef

372. ZarateN, MohammedSD, O'ShaughnessyE, et al.Accurate localization of a fall in pH within the ileocecal region: validation using a dual‐scintigraphic technique. Am J Physiol Gastrointest Liver Physiol2010;299:G1276. CrossRef

373. SarosiekI, SeloverKH, KatzLA, et al.The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther2010;31:313.

374. CamilleriM, ThorneNK, RingelY, et al.Wireless pH‐motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil2010;22:874, e233. CrossRef

375. RaoSS, KuoB, McCallumRW, et al.Investigation of colonic and whole‐gut transit with wireless motility capsule and radiopaque markers in constipation. ClinGastroenterol Hepatol2009;7:537.

376. HaslerWL, SaadRJ, RaoSR, et al.Heightened coln motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS. Am J Physiol Gastrointest Liver Physiol2009;297:G1107. CrossRef

377. KnowlesCH, De GiorgioR, KapurRP, et al.The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut2010;59:882. CrossRef

378. SzurszewskiJH. A migrating electric complex of the canine small intestine. Am J Physiol1969;217:1757.

379. AnurasS, SutherlandJ. Small intestinal manometry in healthy elderly subjects. J Am Geriatr Soc1984;32:581. CrossRef

380. HustonWR, RockrkasseRL, WaldA. Influence of gender and menopause on gastric emptying and motility. Gastroenterology1989;96:11.

381. SugerbakerDJ, MayRJ, GoyalRK. The spectrum of small bowel motility abnormalities in patients with familial hollow visceral myopathy (HVM). Gastroenterology1984;86:1269.

382. AnurasS. Small intestinal manometric studies in patients with familial visceral myopathies (FVM's). Gastroenterology1986;90:1269.

383. TomomasaT, ItohZ, KoizumiT, et al.Manometric study on the intestinal motility in a case of megacystis‐microcolon‐intestinal hypoperistalsis syndrome. J Pediatr Gastroenterol Nutr1985;4:308. CrossRef

384. SofferEE, StrottmannMP, AnurasS. Elevated ANA titers in patients with severely abnormal gastrointestinal motility. Dig Dis Sci1984;29:735. CrossRef

385. MearinF, CamilleriM, MalageladaJR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology1986;90:1919.

386. BattleWM, RubinMR, CohenS, et al.Gastrointestinal motility dysfunction in amyloidosis. N Engl J Med1979;301:24. CrossRef

387. KumarD. Sleep as a modulator of human gastrointestinal motility. Gastroenterology1994;107:1548. CrossRef

388. MalageladaJR, CamilleriM, StanghelliniV. Manometric Diagnosis of Gastrointestinal Motility Disorders. New York: Thieme; 1986.

389. SummersRW, KaracisJJ, AnurasS. Pseudo‐obstruction syndrome in multiple sclerosis. J Gastrointest Motil1991;3:144. CrossRef

390. CamilleriM. Jejunal manometry in distal subacute mechanical obstruction: significance of prolonged simultaneous contractions. Gut1989;30:468. CrossRef

391. FrankJW, SarrMG, CamilleriM. Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction: an analysis of clinical outcome. Am J Gastroenterol1994;89:339.

392. AnurasS, ShiraziS, GardnerGD, et al.Surgical treatments for familial visceral myopathy. Ann Surg1979;189:306. CrossRef

393. AnurasS, ShiraziS. Severe gastrointestinal motility disturbance mimicking bowel obstruction. Clin Surg Int1987;13:1253.

394. PittHA, MannLL, BerquistWE, et al.Chronic intestinal pseudo‐obstruction. Management with total parenteral nutrition and a venting enterostomy. Arch Surg1985;120:614. CrossRef

395. MurrMM, SarrMG, CamilleriM. The surgeon's role in the treatment of chronic intestinal pseudo‐obstruction. Am J Gastroenterol1995;90:2147.

396. FishbeinTM, KaufmanSS, FlormanSS, et al.Isolated intestinal transplantation: proof of clinical efficacy. Transplantation2003;76:636. CrossRef

397. FishbeinTM, MatsumotoCS. Intestinal replacement therapy: timing and indications for referral of patients to an intestinal rehabilitation and transplant program. Gastroenterology2006;130(Suppl 1):S147. CrossRef

398. MasettiM, CauteroN, LauroA, et al.Three‐year experience in clinical intestinal transplantation. Transplant Proc2004;36:309. CrossRef

399. HowardL, MaloneM. Current status of home parenteral nutrition in the United States. Transplant Proc1996;28:2691.

400. ThompsonJS. Intestinal transplantation. Experience in the United States. Eur J Pediatr Surg1999;9:271. CrossRef

401. MadariagaJR, ReyesJ, MazariegosG, et al.The long‐term efficacy of multivisceral transplantation. Transplant Proc2000;32:1219. CrossRef

402. MaedaH, YamagataA, NishikawaS, et al.Requirement of c‐kit for development of intestinal pacemaker system. Development1992;116:369.

403. HuizingaJD, ThunebergL, KluppelM, et al.W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature1995;373:347. CrossRef

404. LeeJC, ThunebergL, BerezinI, et al.Generation of slow waves in membrane potential is an intrinsic property of interstitial cells of Cajal. Am J Physiol1999;277:G409.

405. HuizingaJD, ThunebergL, VanderwindenJM, et al.Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders. Trends Pharmacol Sci1997;18:393. CrossRef

406. SandersKM, PublicoverNG, WardSM. Involvement of interstitial cells of Cajal in pacemaker activity of canine colon. J Smooth Muscle Res1991;27:1. CrossRef

407. WardSM, HarneySC, BayguinovJR, et al.Development of electrical rhythmicity in the murine gastrointestinal tract is specifically encoded in the tunica muscularis. J Physiol1997;505:241. CrossRef

408. VanderwindenJM, RumessenJJ, LiuH, et al.Interstitial cells of Cajal in human colon and in Hirschsprung disease. Gastroenterology1996;111:901. CrossRef

409. IsozakiK, HirotaS, MiyagawaJ, et al.Deficiency of c‐kit+ cells in patients with a myopathic form of chronic idiopathic intestinal pseudo‐obstruction. Am J Gastroenterol1997;92:332.

410. HeCL, BurgartL, WangL, et al.Decreased interstitial cell of cajal volume in patients with slow‐transit constipation. Gastroenterology2000;118:14. CrossRef

411. LyfordGL, HeCL, SofferE, et al.Pan‐colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut2002;51:496. CrossRef

412. WedelT, SpieglerJ, SoellnerS, et al.Enteric nerves and interstitial cells of Cajal are altered in patients with slow‐transit constipation and megacolon. Gastroenterology2002;123:1459. CrossRef

413. KennySE, VanderwindenJM, RintalaRJ, et al.Delayed maturation of the interstitial cells of Cajal: a new diagnosis for transient neonatal pseudoobstruction. Report of two cases. J Pediatr Surg1998;33:94. CrossRef

414. BurnsAJ, RobertsRR, BornsteinJC, et al.Development of the enteric nervous system and its role in intestinal motility during fetal and early postnatal stages. Semin Pediatr Surg2009;18:196. CrossRef

415. VannucchiMG, De GiorgioR, Faussone‐PellegriniMS. NK1 receptor expression in the interstitial cells of Cajal and neurons and tachykinins distribution in rat ileum during development. J Comp Neurol1997;383:153. CrossRef

416. Faussone‐PellegriniMS, FocianiP, BuffaR, et al.Loss of interstitial cells and a fibromuscular layer on the luminal side of the colonic circular muscle presenting as megacolon in an adult patient. Gut1999;45:775. CrossRef

417. BassottiG, VillanacciV, MaurerCA, et al.The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut2006;55:41. CrossRef

418. MisiewiczJJ. Human colonic motility. Scand J Gastroenterol1984;19(Suppl 93):43.

419. ConnellAM. The motility of the pelvic colon. 1. Motility in normals and in patients with asymptomatic duodenal ulcer. Gut1961;2:175. CrossRef

420. KerlinP, ZinsmeisterA, PhillipsS. Motor responses to food of the ileum, proximal colon, and distal colon of healthy humans. Gastroenterology1983;84:762.

421. HoldstockDJ, MisiewiczJJ. Factors controlling colonic motility: colonic pressures and transit after meals in patients with total gastrectomy, pernicious anemia or duodenal ulcer. Gut1970;11:100. CrossRef

422. HoldstockDJ, MisiewiczJJ, SmithT, et al.Propulsion (mass movements) in the human colon and its relationship to meals and somatic activity. Gut1970;11:91. CrossRef

423. DuthieHL. Colonic response to eating. Gastroenterology1978;75:527.

424. WileyJ, TatumD, KeinathR, et al.Participation of gastric mechanoreceptors and intestinal chemoreceptors in the gastrocolonic response. Gastroenterology1988;94:1144.

425. DinningPG, SzczesniakM, CookIJ. Removal of tonic nitrergic inhibition is a potent stimulus for human proximal colonic propagating sequences. Neurogastroenterol Motil2006;18:37. CrossRef

426. NarducciF, BassottiG, GaburriM, et al.Twenty‐four hour manometric recording of colonic motor activity in healthy man. Gut1987;28:17. CrossRef

427. PrestonDM, Lennard‐JonesJE. Pelvic motility and response to intraluminal bisacodyl in slow transit constipation. Dig Dis Sci1985;30:289. CrossRef

428. KamathPS, PhillipsSF, O'ConnorMK, et al.Colonic capacitance and transit in man: modulation by luminal contents and drugs. Gut1990;31:443. CrossRef

429. HerveS, SavoyeG, BehbahaniA, et al.Results of 24‐h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. Neurogastroenterol Motil2004;16:397. CrossRef

430. NeriM, PhillipsSF, FichAF. Measurement of tone in the canine colon. Am J Physiol1991;260:G505.

431. ChoiM‐G, CamilleriM, O'BrienMD, et al.A pilot study of motility and tone of the left colon in diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol1997;92:297.

432. O'BrienMD, CamilleriM, Von der OheMR, et al.Motility and tone of the left colon in constipation: a role in clinical practice?Am J Gastroenterol1996;91:2532.

433. Von der OheMR, HansonRB, CamilleriM. Serotoninergic mediation of postprandial colonic, tonic, and phasic responses in humans. Gut1994;35:536. CrossRef

434. SimsMA, HaslerWL, CheyWD, et al.Hyperglycemia inhibits mechanoreceptor‐mediated gastrocolonic responses and colonic peristaltic reflexes in healthy humans. Gastroenterology1995;108:350. CrossRef

435. BellAM, PembertonJH, HansonRB, et al.Variation of muscle tone of the human rectum: recordings with an electromechanical barostat. Am J Physiol1991;23:G17.

436. GrotzRL, PembertonJH, LevinKE, et al.Rectal wall contractility in healthy subjects and in patients with chronic severe constipation. Ann Surg1993;21:761. CrossRef

437. HammerJ, PhillipsSF, TalleyNJ, et al.Effect of a 5‐HT3 antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Aliment Pharmacol Ther1993;7:543. CrossRef

438. MusialF, CrowellMD. Rectal adaptation to distension: implications for the determination of perception thresholds. Physiol Behav1995;58:1145. CrossRef

439. PriorA, MaxtonDG, WhorwellPJ. Anorectal manometry in irritable bowel syndrome: differences between diarrhea and constipation predominant subjects. Gut1990;31:458. CrossRef

440. KrishnamurthyS, SchufflerMD, RohrmannCA, et al.Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology1985;88:26. CrossRef

441. KochTR, CarneyJA, GoL, et al.Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide. Gastroenterology1988;94:300.

442. SchoutenWR, ten KateFJ, de GraafEJ, et al.Visceral neuropathy in slow transit constipation: an immunohistochemical investigation with monoclonal antibodies against neurofilament. Dis Colon Rectum1993;36:1112. CrossRef

443. PorterAJ, WattchowDA, HunterA, et al.Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation. Int J Colorectal Dis1998;13:208. CrossRef

444. TzavellaK, RieplRL, KlauserAG, et al.Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol1996;8:1207. CrossRef

445. CortesiniC, CianchiF, InfantinoA, et al.Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation. Dig Dis Sci1995;40:2450. CrossRef

446. ParkHJ, KammMA, AbbasiAM, et al.Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation. Dis Colon Rectum1995;38:509. CrossRef

447. HutsonJM, ChowCW, HurleyMR, et al.Deficiency of substance P‐immunoreactive nerve fibres in children with intractable constipation: a form of intestinal neuronal dysplasia. J Paediatr Child Health1997;33:187. CrossRef

448. SjolundK, FasthS, EkmanR, et al.Neuropeptides in idiopathic chronic constipation (slow transit constipation). Neurogastroenterol Motil1997;9:143. CrossRef

449. El‐SalhyM, NorrgardO, SpinnellS. Abnormal colonic endocrine cells in patients with chronic idiopathic slow‐transit constipation. Scand J Gastroenterol1999;34:1007. CrossRef

450. Faussone‐PellegriniMS, InfantinoA, MatiniP, et al.Neuronal anomalies and normal muscle morphology at the hypomotile ileocecocolonic region of patients affected by idiopathic chronic constipation. Histol Histopathol1999;14:1119.

451. PrestonDM, Lennard‐JonesJE, ThomasBM. Towards a radiologic definition of idiopathic megacolon. Gastrointest Radiol1985;10:167. CrossRef

452. HolbertRD, MagirisE, HirschCP, et al.Chagas disease: a case in south Mississippi. J Miss State Med Assoc1995;36:1.

453. TobonF, ReinNC, TalbertJL, et al.Nonsurgical test for the diagnosis of Hirschsprung disease. N Engl J Med1968;278:188. CrossRef

454. PassargeE. The genetics of Hirschsprung disease. Evidence for heterogeneous etiology and a study of sixty‐three families. N Engl J Med1967;276:138. CrossRef

455. IkawaH, KimSH, HendrenWH, et al.Acetylcholinesterase and manometry in the diagnosis of the constipated child. Arch Surg1986;121:435. CrossRef

456. VinoresSA, MayE. Neuron‐specific enolase as an immunohistochemical tool for the diagnosis of Hirschsprung disease. Am J Surg Pathol1985;9:281. CrossRef

457. GunnarsdóttirA, WesterT. Modern treatment of Hirschsprung's disease. Scand J Surg2011;100:243.

458. SkinnerMA. Hirschsprung disease. Curr Probl Surg1996;33:389. CrossRef

459. NeilsonIR, YazbeckS. Ultrashort Hirschsprung disease: myth or reality. J Pediatr Surg1990;25:1135. CrossRef

460. BarnesPRH, Lennard‐JonesJE, HawleyPR, et al.Hirschsprung disease and idiopathic megacolon in adults and adolescents. Gut1986;27:534. CrossRef

461. OgilvieH. Large intestinal colic due to sympathetic deprivation: a new clinical syndrome. Br Med J1948;2:671. CrossRef

462. VanekVW, Al‐SaltiM. Acute pseudo‐obstruction of the colon (Ogilvie's syndrome): an analysis of 400 cases. Dis Colon Rectum1986;29:203. CrossRef

463. BasiliscoG, PhillipsSF. Ileal distention relaxes the canine colon: a model of megacolon. Gastroenterology1994;106:606.

464. JetmoreAB, TimmckeAE, GathrightJB, et al.Ogilvie's syndrome: colonoscopic decompression and analysis of predisposing factors. Dis Colon Rectum1992;35:1135. CrossRef

465. HutchinsonR, GriffithsC. Acute colonic pseudo‐obstruction: a pharmacological approach. Ann R Coll Surg Engl1992;74:364.

466. SloyerAF, PanellaVS, DemasBE, et al.Ogilvie's syndrome. Successful management without colonoscopy. Dig Dis Sci1988;33:1391. CrossRef

467. PonecRJ, SaundersMD, KimmeyMB. Neostigmine for the treatment of acute colonic pseudo‐obstruction. N Engl J Med1999;341:137. CrossRef

468. SgourosSN, VlachogiannakosJ, VassiliadisK, et al.Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut2006;55:638. CrossRef

469. VassalloM, CamilleriM, PhillipsSF, et al.Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology1992;102:102.

470. Von der OheM, CamilleriM, KvolsLK, et al.Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med1993;329:1073. CrossRef

471. Von der OheMR, CamilleriM, KvolsLK. A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology1994;106:1184.

472. CannPA, ReadNW, BrownC, et al.Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut1983;24:405. CrossRef

473. PembertonJH, RathDM, IlstrupDM. Evaluation and surgical treatment of severe chronic constipation. Ann Surg1991;214:403. CrossRef

474. CamilleriM, McKinzieS, BusciglioI, et al.Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol2008;6:772. CrossRef

475. ConnellAM. The motility of the pelvic colon. II. Paradoxical motility in diarrhea and constipation. Gut1962;3:342. CrossRef

476. ReddySN, BazzocchiG, ChanS, et al.Colonic motility and transit in health and ulcerative colitis. Gastroenterology1991;101:1289.

477. CoulieB, CamilleriM, BharuchaAE, et al.Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol Ther2001;15:653. CrossRef

478. RaoSSC, ReadNW, StobhartJAH, et al.Anorectal contractility under basal conditions and during rectal infusion of saline in ulcerative colitis. Gut1988;29:769. CrossRef

479. KarausM, SarnaSK. Giant migrating contractions during defecation in the dog colon. Gastroenterology1987;92:925.

480. FrexinosJ, StaumontG, FioramontiJ, et al.Effects of sennosides on colonic myoelectrical activity in man. Dig Dis Sci1989;34:214. CrossRef

481. BarrowL, SteedKP, SpillerRC, et al.Scintigraphic demonstration of lactulose‐induced accelerated proximal colon transit. Gastroenterology1992;103:1167.

482. CamilleriM. Scintigraphic biomarkers for colonic dysmotility. Clin Pharmacol Ther2010;87:748. CrossRef

483. SteadmanCJ, PhillipsSF, CamilleriM, et al.Control of muscle tone in the human colon. Gut1992;33:541. CrossRef

484. PriorA, ReadNW. Reduction of rectal sensitivity and post‐prandial motility by granisetron, a 5 HT3‐receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther1993;7:175. CrossRef

485. DelvauxM, LouvelD, MametJP, et al.Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther1998;12:849. CrossRef

486. ZighelboimJ, TalleyNJ, PhillipsSF, et al.Visceral perception in irritable bowel syndrome: rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci1995;40:819. CrossRef

487. CamilleriM, NorthcuttAR, KongS, et al.Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo‐controlled trial. Lancet2000;355:1035. CrossRef

488. CamilleriM, CheyWY, MayerEA, et al.A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea‐predominant irritable bowel syndrome. Arch Intern Med2001;161:1733. CrossRef

489. FriedelD, ThomasR, FisherRS. Ischemic colitis during treatment with alosetron. Gastroenterology2001;120:557. CrossRef

490. BriejerMR, GhoosE, EelenJ, et al.Serotonin 5‐HT4 receptors mediate the R093877‐induced changes in contractile patterns in the canine colon. Gastroenterology1997;112:A705.

491. EmmanuelAV, KammMA, RoyAJ, et al.Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers. Gut1998;42:511. CrossRef

492. BourasEP, CamilleriM, BurtonDD, et al.Selective stimulation of colonic transit by the benzofuran 5‐HT4 agonist, prucalopride, in healthy humans. Gut1999;44:682. CrossRef

493. BourasEP, CamilleriM, BurtonDD, et al.Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology2001;120:354. CrossRef

494. DegenL, MatzingerD, MerzM, et al.Tegaserod (HTF 919), a 5‐HT4 receptor partial agonist, accelerates gastrointestinal transit. Gastroenterology2000;118:A845. CrossRef

495. JohansonJF, WaldA, TougasG, et al.Effect of tegaserod in chronic constipation: a randomized, double‐blind, controlled trial. Clin Gastroenterol Hepatol2004;2:796. CrossRef

496. KammMA, Muller‐LissnerS, TalleyNJ, et al.Tegaserod for the treatment of chronic constipation: a randomized, double‐blind, placebo‐controlled multinational study. Am J Gastroenterol2005;100:362. CrossRef

497. FriedM, JohansonJF, GweeKA, et al.Efficacy of tegaserod in chronic constipation in men. Am J Gastroenterol2007;102:362. CrossRef

498. Muller‐LissnerS, KammMA, MusogluA, et al.Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation. Am J Gastroenterol2006;101:2558. CrossRef

499. PasrichaPJ. Desperately seeking serotonin … A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology2007;132:2287. CrossRef

500. PotetF, BouyssouT, EscandeD, et al.Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether‐a‐gogo K(+) channel. JPharmacol ExpTher2001;299:1007.

501. CamilleriM, KerstensR, RykxA, et al.A placebo‐controlled trial of prucalopride for severe chronic constipation. NEngl JMed2008;358:2344. CrossRef

502. TackJ, CorsettiM. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation. Expert Opin Drug Metab Toxicol2012;8:1327. CrossRef

503. CamilleriM, BharuchaAE, UenoR, et al.Effect of a chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory and motor functions in healthy humans. Am J Physiol2006;290:G942.

504. AndresenV, CamilleriM, BusciglioIA, et al.Effect of 5 days linaclotide on transit and bowel function in females with constipation‐predominant irritable bowel syndrome. Gastroenterology2007;133:761. CrossRef

505. LemboAJ, JohansonJF, ParkmanHP, et al.Long‐term safety and effectiveness of lubiprostone, a chloride channel (ClC‐2) activator, in patients with chronic idiopathic constipation. Dig Dis Sci2011;56:2639. CrossRef

506. CheyWD, LemboAJ, LavinsBJ, et al.Linaclotide for irritable bowel syndrome with constipation: a 26‐week, randomized, double‐blind, placebo‐controlled trial to evaluate efficacy and safety. Am J Gastroenterol2012;107:1702. CrossRef

507. PachnisV, DurbecP, TaravirasS, et al.Role of the RET signal transduction pathway in development of the mammalian enteric nervous system. Am J Physiol1998;275:G183.

508. SweetserS, CamilleriM. Clinical challenges and images in GI. Hindgut dysgenesis with megacolon. Gastroenterology2008;134:1635. CrossRef

509. EderyP, LyonnetS, MulliganLM, et al.Mutations of the RET proto‐oncogene in Hirschsprung's disease. Nature1994;367:378. CrossRef

510. GoreRM, MintzerRA. Gastrointestinal complications. In: Calenoff L(ed). Radiology of the Spinal Cord. St. Louis: CV Mosby; 1981: 287.

511. LoftusEV, FarrugiaG, DonohueJH, et al.Duodenal obstruction: diagnosis by gastroduodenal manometry. Mayo Clin Proc1997;72:130. CrossRef